Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy
15 mai 2023 13h34 HE
|
InSilico Medicine
Abu Dhabi, May 15, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice...
Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy
15 mai 2023 13h20 HE
|
InSilico Medicine
Hong Kong, May 15, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice...
Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy
15 mai 2023 12h45 HE
|
InSilico Medicine
New York, May 15, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice...
Insilico Medicine Founder and CEO to Give Keynote on Disease Modeling with AI at PEGS Boston
12 mai 2023 16h39 HE
|
InSilico Medicine
Abu Dhabi, May 12, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that Alex Zhavoronkov, PhD, founder and CEO of the...
UAE Biotech Insilico Medicine Offers Disease Modeling and Target Identification Course Using AI
12 mai 2023 08h40 HE
|
InSilico Medicine
Abu Dhabi, May 12, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that it is releasing a course on Disease Modeling...
AI Drug Discovery Company Insilico Medicine Offers Free Course on Target Identification
10 mai 2023 09h00 HE
|
InSilico Medicine
New York, May 10, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced today that it is releasing a course on Disease...
Head of Insilico Medicine’s Hong Kong R&D Center to Give Keynote on AI Drug Discovery at HKUST Big Data Institute
04 mai 2023 14h03 HE
|
InSilico Medicine
Hong Kong, May 04, 2023 (GLOBE NEWSWIRE) -- Frank Pun, PhD, Head of the Hong Kong R&D Center of Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven drug discovery...
High School Student Researchers Find New Brain Tumor Drug Targets Using AI
02 mai 2023 09h00 HE
|
InSilico Medicine
New York, May 02, 2023 (GLOBE NEWSWIRE) -- Three high school students – Andrea Olsen from Oslo, Norway; Zachary Harpaz from Boca Raton, Florida; and Chris Ren from Shanghai, China – co-authored a...
Student Researchers Use UAE-Developed Generative AI Technology to Find New Brain Tumor Drug Targets
02 mai 2023 09h00 HE
|
InSilico Medicine
Abu Dhabi, May 02, 2023 (GLOBE NEWSWIRE) -- Three high school students – Andrea Olsen from Oslo, Norway; Zachary Harpaz from Boca Raton, Florida; and Chris Ren from Shanghai, China – co-authored a...
Insilico Medicine Successfully Discovered Potent, Selective, and Orally Bioavailable Small Molecule Inhibitor of CDK8 Using Generative AI
24 avr. 2023 15h14 HE
|
InSilico Medicine
Abu Dhabi, April 24, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company which operates the largest...